Lexington Biomedical, Inc.

CIK: 2057514•DE•Incorporated: 2013-09-26

Latest Reported Offering

$124,000
Target Amount
$1,234,996
Maximum Amount
2025-04-30
Deadline

Security Details

Type: Other
Price per share: $1.23
Price set by: N/A
Shares offered: 100,813+

Offering Costs

Cash commission: —
7 - 13 percent
Equity compensation: —
One percent (1%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Filing history

Form C family — 2 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
2025-04-21C-U020-35676StartEngine Primary LLC$124K target, up to $1.2M · Series A Preferred Stock at $1.23 · closes 2025-04-30The Issuer closed on $0 and no securities.
2025-03-17C020-35676StartEngine Primary LLC$124K target, up to $1.2M · Series A Preferred Stock at $1.23 · closes 2025-04-30—
Embarc dashboard

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist
Open in the dashboard

Company Information

Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2013-09-26

Latest Metrics

Employees2
Total Assets$57,189
Cash on Hand$18,710
Revenues$0.00
Net Income-$304,063

Crowdfunding Portals

The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.